CZ20031502A3 - Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují - Google Patents

Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují

Info

Publication number
CZ20031502A3
CZ20031502A3 CZ20031502A CZ20031502A CZ20031502A3 CZ 20031502 A3 CZ20031502 A3 CZ 20031502A3 CZ 20031502 A CZ20031502 A CZ 20031502A CZ 20031502 A CZ20031502 A CZ 20031502A CZ 20031502 A3 CZ20031502 A3 CZ 20031502A3
Authority
CZ
Czechia
Prior art keywords
ortho
meta
comprised
pharmaceutical preparations
bisaryl compounds
Prior art date
Application number
CZ20031502A
Other languages
English (en)
Other versions
CZ301631B6 (cs
Inventor
Stefan Peukert
Joachim Brendel
Horst Hemmerle
Heinz-Werner Kleemann
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of CZ20031502A3 publication Critical patent/CZ20031502A3/cs
Publication of CZ301631B6 publication Critical patent/CZ301631B6/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CZ20031502A 2000-11-30 2001-11-17 Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují CZ301631B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10059418A DE10059418A1 (de) 2000-11-30 2000-11-30 Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen

Publications (2)

Publication Number Publication Date
CZ20031502A3 true CZ20031502A3 (cs) 2003-08-13
CZ301631B6 CZ301631B6 (cs) 2010-05-05

Family

ID=7665215

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20031502A CZ301631B6 (cs) 2000-11-30 2001-11-17 Ortho- a meta-substituované bisarylové slouceniny a farmaceutické prostredky, které je obsahují

Country Status (28)

Country Link
US (2) US6605625B2 (cs)
EP (1) EP1339675B1 (cs)
JP (1) JP4051283B2 (cs)
KR (1) KR100968056B1 (cs)
CN (1) CN1290825C (cs)
AR (1) AR031430A1 (cs)
AT (1) ATE289292T1 (cs)
AU (2) AU2793102A (cs)
BR (1) BR0115769A (cs)
CA (1) CA2430273C (cs)
CZ (1) CZ301631B6 (cs)
DE (2) DE10059418A1 (cs)
EE (1) EE05240B1 (cs)
ES (1) ES2236341T3 (cs)
HR (1) HRP20030436B1 (cs)
HU (1) HUP0303317A3 (cs)
IL (2) IL156097A0 (cs)
MX (1) MXPA03004386A (cs)
NO (1) NO328599B1 (cs)
NZ (1) NZ526177A (cs)
PL (1) PL206245B1 (cs)
PT (1) PT1339675E (cs)
RS (1) RS50403B (cs)
RU (1) RU2278858C2 (cs)
SK (1) SK286708B6 (cs)
TW (1) TWI254039B (cs)
WO (1) WO2002044137A1 (cs)
ZA (1) ZA200303893B (cs)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10060807A1 (de) * 2000-12-07 2002-06-20 Aventis Pharma Gmbh Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
GB0124936D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124931D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124938D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124933D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124939D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124934D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
GB0124941D0 (en) * 2001-10-17 2001-12-05 Glaxo Group Ltd Chemical compounds
RU2309951C2 (ru) 2002-02-12 2007-11-10 Смитклайн Бичем Корпорейшн Производные никотинамида, способы их получения, фармацевтическая композиция на их основе и применение
GB0217757D0 (en) 2002-07-31 2002-09-11 Glaxo Group Ltd Novel compounds
JP2006500372A (ja) 2002-08-19 2006-01-05 グラクソ　グループ　リミテッド 選択的ｃｏｘ−２阻害物質としてのピリミジン誘導体
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
CA2508171C (en) * 2002-12-13 2012-08-28 Cytopia Pty Ltd Nicotinamide-based kinase inhibitors
ES2571779T3 (es) * 2002-12-13 2016-05-26 Ym Biosciences Australia Pty Inhibidores de cinasa a base de nicotinamida
AU2003291839B2 (en) * 2002-12-13 2009-01-22 Ym Biosciences Australia Pty Ltd Nicotinamide-based kinase inhibitors
GB0308185D0 (en) * 2003-04-09 2003-05-14 Smithkline Beecham Corp Novel compounds
GB0315950D0 (en) 2003-06-11 2003-08-13 Xention Discovery Ltd Compounds
DE10341233A1 (de) * 2003-09-08 2005-03-24 Aventis Pharma Deutschland Gmbh Kombination von Phenylcarbonsäureamiden mit beta-Adrenozeptoren-Blockern und deren Verwendung zur Behandlung von Vorhofarrhythmien
US20050054673A1 (en) * 2003-09-08 2005-03-10 Aventis Pharma Deutschland Gmbh Combination of phenylcarboxylic acid amides with beta-adrenoreceptor blockers and their use for the treatment of atrial arrhythmias
EP1667979A4 (en) * 2003-09-23 2007-04-18 Merck & Co Inc INHIBITORS OF POTASSIUM CHANNELS WITH ISOQUINOLINE
US7647300B2 (en) * 2004-01-26 2010-01-12 Google Inc. Methods and systems for output of search results
GB0402143D0 (en) * 2004-01-30 2004-03-03 Smithkline Beecham Corp Novel compounds
GB0403744D0 (en) * 2004-02-20 2004-03-24 Astrazeneca Ab Chemical process
EP1725236A4 (en) * 2004-03-11 2009-05-13 Glaxo Group Ltd NEW M3 MUSCARIN ACETYLCHOLINE RECEPTOR ANTAGONISTS
GB0412986D0 (en) 2004-06-10 2004-07-14 Xention Discovery Ltd Compounds
WO2006014877A2 (en) * 2004-07-29 2006-02-09 Merck & Co., Inc. Potassium channel inhibitors
US7569589B2 (en) 2004-07-29 2009-08-04 Merck & Co., Inc. Potassium channel inhibitors
US20080051416A1 (en) * 2004-10-05 2008-02-28 Smithkline Beecham Corporation Novel Compounds
EP1957075A4 (en) 2004-11-15 2009-11-18 Glaxo Group Ltd NOVEL ANTAGONISTS OF ACETYLCHOLINE M3 TYPE MUSCARINIC RECEPTORS
US7576212B2 (en) 2004-12-09 2009-08-18 Xention Limited Thieno[2,3-B] pyridines as potassium channel inhibitors
GB0512429D0 (en) * 2005-06-17 2005-07-27 Smithkline Beecham Corp Novel compound
US8278317B2 (en) * 2005-07-22 2012-10-02 Merck Sharp & Dohme Corp. Potassium channel inhibitors
GB0525164D0 (en) 2005-12-09 2006-01-18 Xention Discovery Ltd Compounds
AU2007245891B2 (en) * 2006-04-27 2012-10-18 Sanofi-Aventis Deutschland Gmbh Inhibitors of the TASK-1 and TASK-3 ion channel
TW200845991A (en) 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: hydroxylase inhibitors
WO2008124614A1 (en) 2007-04-06 2008-10-16 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
ES2534573T3 (es) 2007-04-06 2015-04-24 Neurocrine Biosciences, Inc. Antagonistas del receptor de la hormona liberadora de gonadotropina y métodos relacionados con los mismos
GB0815781D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB201105659D0 (en) 2011-04-01 2011-05-18 Xention Ltd Compounds
NO3175985T3 (cs) 2011-07-01 2018-04-28
CA2862670A1 (en) 2012-01-27 2013-08-01 Gilead Sciences, Inc. Combination therapies using late sodium ion channel blockers and potassium ion channel blockers
TWI773657B (zh) 2015-12-18 2022-08-11 美商亞德利克斯公司 作爲非全身ｔｇｒ５促效劑之經取代之4-苯基吡啶化合物
US12084472B2 (en) 2015-12-18 2024-09-10 Ardelyx, Inc. Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonists
CN107573292B (zh) * 2017-09-04 2022-06-24 江苏艾立康医药科技有限公司 作用于脯氨酰羟化酶的吡嗪衍生化合物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97219A (en) * 1990-02-19 1995-12-08 Ciba Geigy Ag Biphenyl substituted aliphatic amino compounds process for their preparation and pharmaceutical compositions containing them
GB9220137D0 (en) * 1992-09-23 1992-11-04 Pfizer Ltd Therapeutic agents
WO1995001326A1 (en) * 1993-06-30 1995-01-12 The Wellcome Foundation Limited Anti-atherosclerotic diaryl compounds
GB9416972D0 (en) * 1994-08-23 1994-10-12 Smithkline Beecham Plc Carbon side chain/indole/indolene
DE4430638A1 (de) 1994-08-29 1996-03-07 Bayer Ag Verwendung von substituierten 4-Phenyl-6-amino-nicotinsäurederivaten als Arzneimittel
DE4432101A1 (de) 1994-09-09 1996-03-14 Hoechst Ag Aminosäure-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
US5670504A (en) 1995-02-23 1997-09-23 Merck & Co. Inc. 2,6-diaryl pyridazinones with immunosuppressant activity
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US5969017A (en) 1996-10-31 1999-10-19 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
US5935945A (en) 1996-10-31 1999-08-10 Merck & Co., Inc. Methods of treating or preventing cardiac arrhythmia
KR100241350B1 (ko) * 1997-10-27 2000-02-01 정선종 전자 거래에서 안전한 전자 공증문서 생성방법
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
JP2002523451A (ja) * 1998-09-01 2002-07-30 ブリストル−マイヤーズ スクイブ カンパニー カリウムチャネル抑制剤および方法
CN1325380A (zh) * 1998-09-11 2001-12-05 味之素株式会社 苯衍生物和它们的药物用途
DE19947457A1 (de) * 1999-10-02 2001-04-05 Aventis Pharma Gmbh 2'-Substituierte 1,1'-Biphenyl-2-carbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
NO328599B1 (no) 2010-03-29
US6605625B2 (en) 2003-08-12
CN1290825C (zh) 2006-12-20
ATE289292T1 (de) 2005-03-15
AU2793102A (en) 2002-06-11
AR031430A1 (es) 2003-09-24
EP1339675A1 (de) 2003-09-03
AU2002227931B2 (en) 2006-07-13
JP2004514707A (ja) 2004-05-20
RU2278858C2 (ru) 2006-06-27
CA2430273A1 (en) 2002-06-06
DE50105386D1 (de) 2005-03-24
HUP0303317A3 (en) 2010-04-28
MXPA03004386A (es) 2003-09-04
RS37603A (en) 2006-12-15
NO20032438D0 (no) 2003-05-28
JP4051283B2 (ja) 2008-02-20
CA2430273C (en) 2010-02-09
HRP20030436A2 (en) 2005-04-30
NZ526177A (en) 2004-11-26
HUP0303317A2 (hu) 2004-01-28
IL156097A (en) 2010-11-30
DE10059418A1 (de) 2002-06-20
RS50403B (sr) 2009-12-31
NO20032438L (no) 2003-07-09
CZ301631B6 (cs) 2010-05-05
US6924392B2 (en) 2005-08-02
PT1339675E (pt) 2005-04-29
US20030013719A1 (en) 2003-01-16
KR20030062364A (ko) 2003-07-23
EE05240B1 (et) 2009-12-15
WO2002044137A1 (de) 2002-06-06
CN1494527A (zh) 2004-05-05
KR100968056B1 (ko) 2010-07-08
TWI254039B (en) 2006-05-01
SK6532003A3 (en) 2003-12-02
ES2236341T3 (es) 2005-07-16
HK1061231A1 (en) 2004-09-10
PL206245B1 (pl) 2010-07-30
EP1339675B1 (de) 2005-02-16
HRP20030436B1 (en) 2006-04-30
ZA200303893B (en) 2004-04-15
BR0115769A (pt) 2004-01-13
US20030225099A1 (en) 2003-12-04
PL362700A1 (en) 2004-11-02
EE200300183A (et) 2003-06-16
SK286708B6 (sk) 2009-03-05
IL156097A0 (en) 2003-12-23

Similar Documents

Publication Publication Date Title
CZ20031502A3 (cs) Ortho- a meta-substituované bisarylové sloučeniny a farmaceutické prostředky, které je obsahují
NO20071303L (no) Farmasoytiske preparater
EE200200038A (et) Konservitud farmatseutilised preparaadid
IL152659A0 (en) Pharmaceutical composition
SI1524266T1 (sl) Farmacevtski sestavek
HUP0204555A3 (en) Pharmaceutical composition
ATE332132T1 (de) Verbesserte arzneizubereitungen enthaltend ritonavir
GB0025473D0 (en) Pharmaceutical combinations
HUP0300334A3 (en) Pharmaceutical preparations and their manufacture
IL154238A0 (en) Pharmaceutical composition
EP1325751A4 (en) NEW MEDICAMENTS FOR THE TREATMENT OF LIVER DISEASES
GB0019228D0 (en) Novel pharmaceutical
GB0021865D0 (en) Novel pharmaceutical
GB0005382D0 (en) Pharmaceutical composition
GB0014006D0 (en) Novel pharmaceutical
GB0019226D0 (en) Novel pharmaceutical
GB0019224D0 (en) Novel pharmaceutical
GB0021487D0 (en) Pharmaceutical
GB0014005D0 (en) Novel pharmaceutical
GB0023971D0 (en) Novel pharmaceutical
ZA200205556B (en) Pharmaceutical compositions and their preparation.
GB0019223D0 (en) Novel pharmaceutical
GB0023970D0 (en) Novel pharmaceutical
GB0021785D0 (en) Novel Pharmaceutical
GB0029537D0 (en) Dual therapeusis and dual potencies in pharmaceutical preparations

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20111117